Mruk-Mazurkiewicz, H.; Kulaszyńska, M.; Jakubczyk, K.; Janda-Milczarek, K.; Czarnecka, W.; Rębacz-Maron, E.; Zacha, S.; Sieńko, J.; Zeair, S.; Dalewski, B.;
et al. Clinical Relevance of Gut Microbiota Alterations under the Influence of Selected Drugs—Updated Review. Biomedicines 2023, 11, 952.
https://doi.org/10.3390/biomedicines11030952
AMA Style
Mruk-Mazurkiewicz H, Kulaszyńska M, Jakubczyk K, Janda-Milczarek K, Czarnecka W, Rębacz-Maron E, Zacha S, Sieńko J, Zeair S, Dalewski B,
et al. Clinical Relevance of Gut Microbiota Alterations under the Influence of Selected Drugs—Updated Review. Biomedicines. 2023; 11(3):952.
https://doi.org/10.3390/biomedicines11030952
Chicago/Turabian Style
Mruk-Mazurkiewicz, Honorata, Monika Kulaszyńska, Karolina Jakubczyk, Katarzyna Janda-Milczarek, Wiktoria Czarnecka, Ewa Rębacz-Maron, Sławomir Zacha, Jerzy Sieńko, Samir Zeair, Bartosz Dalewski,
and et al. 2023. "Clinical Relevance of Gut Microbiota Alterations under the Influence of Selected Drugs—Updated Review" Biomedicines 11, no. 3: 952.
https://doi.org/10.3390/biomedicines11030952
APA Style
Mruk-Mazurkiewicz, H., Kulaszyńska, M., Jakubczyk, K., Janda-Milczarek, K., Czarnecka, W., Rębacz-Maron, E., Zacha, S., Sieńko, J., Zeair, S., Dalewski, B., Marlicz, W., Łoniewski, I., & Skonieczna-Żydecka, K.
(2023). Clinical Relevance of Gut Microbiota Alterations under the Influence of Selected Drugs—Updated Review. Biomedicines, 11(3), 952.
https://doi.org/10.3390/biomedicines11030952
